دورية أكاديمية
Prevalence and risk factors for high-risk human papillomavirus infection among women from three southern geopolitical zones of Nigeria.
| العنوان: | Prevalence and risk factors for high-risk human papillomavirus infection among women from three southern geopolitical zones of Nigeria. |
|---|---|
| المؤلفون: | Onwuamah CK; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria., Feng N; Center for Global Public Health, Chinese Centre for Disease Control and Prevention, Beijing, China., Momoh AE; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria., Uwandu M; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria., Ahmed RA; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.; Division of Allergy and Clinical Immunology, Division of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States., Idigbe I; Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria., Vincent GD; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria., Ogbu CA; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria., Okonkwo N; Department of Obstetrics and Gynaecology, Delta State University Teaching Hospital, Oghara, Delta, Nigeria., Sokei J; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria.; Department of Pediatric Oncology (Hematology), Washington University in St. Louis, St. Louis, MO, United States., Abimbola BS; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria., Ojopagogo T; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria., Okoli LC; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria., Adesina M; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria., Ezemelue PN; Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria., Sowunmi O; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria., Okwuzu J; Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria., Labo Popoola OH; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria., Shaibu JO; Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria., Ohihoin GA; Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria., Nzeribe E; Department of Obstetrics and Gynaecology, Federal Medical Centre, Owerri, Imo, Nigeria., David A; Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria., Olaleye O; Screening Section, Optimal Cancer Care Foundation Centre, Lagos, Nigeria., Ofotokun I; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States., Dong XP; Center for Global Public Health, Chinese Centre for Disease Control and Prevention, Beijing, China., Ezechi OC; Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria. |
| المصدر: | Frontiers in oncology [Front Oncol] 2023 Oct 09; Vol. 13, pp. 1254304. Date of Electronic Publication: 2023 Oct 09 (Print Publication: 2023). |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: [Lausanne : Frontiers Research Foundation] |
| مستخلص: | Introduction: Human Papillomavirus (HPV) infection is a risk factor for cervical cancer, the fourth most common cancer among women globally. Its burden is the highest in sub-Saharan Africa, with over 90% mortality. Interventions may fail without evidence-based data on stratified prevalence and risk factors among most at-risk women across Nigeria. Methods: A cross-sectional comparative study, with participants recruited from the Nigerian Institute of Medical Research's Clinics, NGO outreaches, a cancer screening centre and a university teaching hospital. Questionnaires were self-administered. Trained medics performed sampling at healthcare facilities, and self-sampling was used at outreaches. Results: Nine hundred eighty-five study participants were recruited. About 37% and 27% of the women knew about HPV and its vaccines, respectively, but only 6% confirmed vaccination with HPV vaccines. HPV prevalence was highest among women with unknown marital status (35.9%), single women (33.8%), widowed/divorced/separated women (30.3%), and married/cohabiting women (19.6%). HPV infection was significantly higher among women who take alcohol (odds=1.7 [95% CI: 1.2-2.4]) and women who smoke (odds=2.6 [95% CI: 1.4 - 4.6]. HPV strains detected included HPV16 (1.3%), HPV18 (1.5%), Low Risk (0.2%) and Other High-Risk groups (19.7%). Conclusion: The inverse relationship between prevalence and education suggests interventions improving awareness and prevention would be impactful. Such interventions could also target HIV-positive women, women presenting with sexually-transmitted infections, who smoke and frequently drink alcohol. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2023 Onwuamah, Feng, Momoh, Uwandu, Ahmed, Idigbe, Vincent, Ogbu, Okonkwo, Sokei, Abimbola, Ojopagogo, Okoli, Adesina, Ezemelue, Sowunmi, Okwuzu, Labo−Popoola, Shaibu, Ohihoin, Nzeribe, David, Olaleye, Ofotokun, Dong and Ezechi.) |
| References: | Arch Gynecol Obstet. 2012 Mar;285(3):771-7. (PMID: 22159694) Pan Afr Med J. 2019 Jun 18;33:125. (PMID: 31558924) Virusdisease. 2021 Jun;32(2):255-259. (PMID: 34350316) BMC Public Health. 2020 Sep 25;20(1):1455. (PMID: 32977797) J Med Virol. 2022 Jul;94(7):3368-3375. (PMID: 35257379) J Immunoassay Immunochem. 2019;40(3):283-288. (PMID: 30794040) Sex Transm Infect. 2022 Jun;98(4):247-254. (PMID: 34187906) PLoS One. 2022 Mar 30;17(3):e0265269. (PMID: 35353833) AIDS. 2018 Mar 27;32(6):795-808. (PMID: 29369827) BMC Infect Dis. 2022 Jan 27;22(1):95. (PMID: 35086475) Eur J Gynaecol Oncol. 2010;31(1):72-4. (PMID: 20349784) Ultrasound Obstet Gynecol. 2018 Jan;51(1):87-93. (PMID: 28608497) Virol J. 2014 Jan 15;11:5. (PMID: 24433568) Int J Environ Res Public Health. 2018 Oct 10;15(10):. (PMID: 30309014) Afr J Reprod Health. 2022 Jun;26(6):89-96. (PMID: 37585061) PLoS One. 2022 Jul 18;17(7):e0270874. (PMID: 35849577) Arch Basic Appl Med. 2018 Feb;6(1):95-98. (PMID: 30294662) Arch Gynecol Obstet. 2015 Dec;292(6):1273-8. (PMID: 25990479) BMC Public Health. 2022 Oct 15;22(1):1922. (PMID: 36243709) Infect Agent Cancer. 2018 Aug 17;13:29. (PMID: 30140306) Asian Pac J Cancer Prev. 2020 Oct 01;21(10):2837-2846. (PMID: 33112538) Germs. 2021 Mar 15;11(1):78-87. (PMID: 33898344) Infect Agent Cancer. 2021 Sep 8;16(1):59. (PMID: 34496909) PLoS One. 2021 Jun 18;16(6):e0253074. (PMID: 34143816) Postepy Dermatol Alergol. 2019 Feb;36(1):76-81. (PMID: 30858783) |
| معلومات مُعتمدة: | D43 TW010934 United States TW FIC NIH HHS |
| فهرسة مساهمة: | Keywords: HPV; Nigeria; cervical cancer; risk factor; women |
| تواريخ الأحداث: | Date Created: 20231025 Latest Revision: 20240210 |
| رمز التحديث: | 20240210 |
| مُعرف محوري في PubMed: | PMC10593479 |
| DOI: | 10.3389/fonc.2023.1254304 |
| PMID: | 37876969 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2234-943X |
|---|---|
| DOI: | 10.3389/fonc.2023.1254304 |